Here's the coronavirus-related news you should know from this week.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 12,291,645 individuals worldwide, and approximately 3.1 million Americans. The latest COVID-19 related news includes changes in pre-exposure prophylaxis (PrEP) utilization and advancements in artificial intelligence (AI) tools in the medical field.
Here’s a roundup of the latest coronavirus-related news:
Survey results on PrEP access and utilization during COVID-19 shelter-in-place orders presented at the 23rd International AIDS Conference.
Many PrEP users reported voluntarily discontinuing therapy during shelter-in-place orders amid the COVID-19 pandemic due to low perceived HIV risk, according to an online survey conducted by The American Academy of HIV Medicine in partnership with Gilead Sciences HIV Medical Affairs.
Drug Topics® interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.
Officials with the FDA recently issued an emergency use authorization (EUA) for the third diagnostic test for the detection and differentiation of the viruses that cause influenza and COVID-19, according to a press release.
Drug Topics® interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that AI can mitigate challenges posed by the COVID-19 pandemic.
In episode 3 of Over the Counter, experts weigh in on remdesivir, a potential COVID-19 treatment.
Listen to the podcast episode.
Kroger Health will start offering its COVID-19 Test Home Collection Kit with the guidance of a telehealth consultation.
The FDA granted an EUA for the COVID-19 Test Home Collection Kit to Kroger Health — making it the first retailer to receive an authorization for a COVID-19 test.